SCLX · NASDAQ · Drug Manufacturers - General

Scilex

Commercializes non-opioid treatments for acute and chronic pain.

$5.43
After-hours close−0.01 (−0.18%)
At close$5.44(−2.33%)
DateEstimateReportedSurprise
Aug 2026−$0.18−$16.65−9,083.2%
May 2026−$0.21−$4.76−2,166.5%
Apr 2026−$0.29−$4.60−1,471.9%
Nov 2025−$13.80−$13.800.0%

The latest year is open to everyone — the 28 quarters behind it read with an account.

Sign in
Aug 2025
Aug 2025
May 2025
Mar 2025
Mar 2025
Jan 2025
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Sep 2022
Jun 2022
Mar 2022
Dec 2021
Sep 2021
Jun 2021
Mar 2021
Dec 2020
Sep 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Aug 14, 2026−$0.18−$16.65−9,083.2%$16.0M$7.6M−52.2%
May 20, 2026−$0.21−$4.76−2,166.5%$15.0M$8.6M−42.6%
Apr 10, 2026−$0.29−$4.60−1,471.9%$12.1M$4.8M−60.4%
Nov 14, 2025−$13.80−$13.800.0%$10.6M$10.6M0.0%

The latest year is open to everyone — the 28 quarters behind it read with an account.

Sign in
Aug 13, 2025
Aug 12, 2025
May 14, 2025
Mar 31, 2025
Mar 17, 2025
Jan 17, 2025
Aug 13, 2024
May 13, 2024
Mar 11, 2024
Nov 14, 2023
Aug 11, 2023
May 12, 2023
Mar 7, 2023
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019